Evidence map›Paper›PMID 21328513›Full record

ArticleChembiochem : a European journal of chemical biology2011

Synthesis and pro-apoptotic activity of novel glycyrrhetinic acid derivatives.

Evgeniya B Logashenko, Oksana V Salomatina, A V Markov, Dina V Korchagina, Nariman F Salakhutdinov, Genrikh A Tolstikov, Valentin V Vlassov, Marina A Zenkova

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. SoloxoloneFrontiers in pharmacology · 2024
    Article
  3. Synthesis and Antiviral and Antitumor Activities of Novel 18International journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Evgeniya B LogashenkoInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, 8, Lavrent'ev avenue, 630090 Novosibirsk, Russian Federation. evg_log@niboch.nsc.ru
Oksana V Salomatina
A V Markov
Dina V Korchagina
Nariman F Salakhutdinov
Genrikh A Tolstikov
Valentin V Vlassov
Marina A Zenkova

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triterpenoids are used for medicinal purposes in many countries. Some, such as oleanolic and glycyrrhetinic acids, are known to be anti-inflammatory and anticarcinogenic. However, the biological activities of these naturally occurring molecules against their particular targets are weak, so the synthesis of new synthetic analogues with enhanced potency is needed. By combining modifications to both the A and C rings of 18βH-glycyrrhetinic acid, the novel synthetic derivative methyl 2-cyano-3,12-dioxo-18βH-olean-9(11),1(2)-dien-30-oate was obtained. This derivative displays high antiproliferative activity in cancer cells, including a cell line with a multidrug-resistance phenotype. It causes cell death by inducing the intrinsic caspase-dependent apoptotic pathway.

Indexed as

Antineoplastic AgentsApoptosisCell Line, TumorGlycyrrhetinic AcidGlycyrrhizaHumansNeoplasmsAntineoplastic AgentsGlycyrrhetinic Acid

Identifiers

PMID21328513
PMCPMC3085123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.